Sutro Biopharma (STRO) Earnings Date, Estimates & Call Transcripts $1.08 +0.18 (+19.44%) As of 03:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Sutro Biopharma Earnings Summary Upcoming Earnings DateMay. 12EstimatedConsensus EPS (Mar. 13) -$0.86 Actual EPS (Mar. 13) -$2.96 Missed By -$2.10 Actual Revenue (Mar. 13) $14.00MSutro Biopharma released Q4 2024 earnings on March 13, 2025, reporting an EPS of -$2.96, which missed the consensus estimate of -$0.86 by $2.10. Quarterly revenue was reported to be $14 million, above analysts' expectations of $10.44 million. With a trailing EPS of -$3.02, Sutro Biopharma's earnings are expected to decrease next year, from ($2.92) to ($2.95) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)STRO Upcoming EarningsSutro Biopharma's Q1 2025 earnings is scheduled for Monday, May 12, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Sutro Biopharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sutro Biopharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSTRO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.STRO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Sutro Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.92-$0.38-$0.65Q2 20252-$0.60-$0.41-$0.51Q3 20252-$0.60-$0.43-$0.52Q4 20252-$0.64-$0.46-$0.55FY 20258($2.76)($1.68)($2.22) Sutro Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)-------3/13/2025Q4 2024-$0.86-$2.96 -$2.10-$0.89$10.44M$14.00M8/13/2024Q2 2024-$0.79-$0.59+$0.20-$0.59$26.28M$25.71M5/13/2024Q1 2024-$0.92-$0.95 -$0.03-$0.95$11.57M$13.01M3/25/2024Q4 2023-$0.82$0.42+$1.24$0.32$12.16M$113.72M11/13/2023Q3 2023-$0.76-$0.81 -$0.05-$0.81$12.08M$16.92M8/10/2023Q2 2023-$0.73-$0.64+$0.09-$0.64$10.45M$10.41M5/15/2023Q1 2023-$0.83-$0.76+$0.07-$0.67$11.35M$12.67M Sutro Biopharma Earnings - Frequently Asked Questions When is Sutro Biopharma's earnings date? Sutro Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on STRO's earnings history. Did Sutro Biopharma beat their earnings estimates last quarter? In the previous quarter, Sutro Biopharma (NASDAQ:STRO) missed the analysts' consensus estimate of ($0.86) by $2.10 with a reported earnings per share (EPS) of ($2.96). Learn more on analysts' earnings estimate vs. STRO's actual earnings. How can I listen to Sutro Biopharma's earnings conference call? The conference call for Sutro Biopharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Sutro Biopharma's conference call transcript? The conference call transcript for Sutro Biopharma's latest earnings report can be read online. Read Transcript How much revenue does Sutro Biopharma generate each year? Sutro Biopharma (NASDAQ:STRO) has a recorded annual revenue of $62.04 million. How much profit does Sutro Biopharma generate each year? Sutro Biopharma (NASDAQ:STRO) has a recorded net income of -$106.79 million. STRO has generated -$3.02 earnings per share over the last four quarters. What is Sutro Biopharma's EPS forecast for next year? Sutro Biopharma's earnings are expected to decrease from ($2.92) per share to ($2.95) per share in the next year. More Earnings Resources from MarketBeat Related Companies SOPH Earnings Results GOSS Earnings Results ANNX Earnings Results HURA Earnings Results DBVT Earnings Results NGNE Earnings Results ELDN Earnings Results VYGR Earnings Results KOD Earnings Results CGC Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InWhy It May Be Time to Buy CrowdStrike Stock Heading Into EarningsCan IBM’s Q1 Earnings Spark a Breakout for the Stock? This page (NASDAQ:STRO) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredA Biotech Power Move? This company is leading the charge in developing advanced antiviral therapies—watch closely!With a revolutionary antiviral drug, this company is in a great position to build shareholder value as this ti...Smallcaps Daily | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sutro Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sutro Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy STRO Stock Free STRO Stock Alerts